Global Oral Insulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Oral Insulin market size was valued at USD 551.5 million in 2023 and is forecast to a readjusted size of USD 794.8 million by 2030 with a CAGR of 5.4% during review period.

The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Oral Insulin industry chain, the market status of Female (Type 1 Diabetes, Type 2 Diabetes), Male (Type 1 Diabetes, Type 2 Diabetes), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Insulin.

Regionally, the report analyzes the Oral Insulin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Insulin market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Oral Insulin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Insulin industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Type 1 Diabetes, Type 2 Diabetes).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Insulin market.

Regional Analysis: The report involves examining the Oral Insulin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Insulin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Oral Insulin:
Company Analysis: Report covers individual Oral Insulin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Insulin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Female, Male).

Technology Analysis: Report covers specific technologies relevant to Oral Insulin. It assesses the current state, advancements, and potential future developments in Oral Insulin areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Insulin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Oral Insulin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Type 1 Diabetes
    Type 2 Diabetes

Market segment by Application
    Female
    Male

Major players covered
    Novo Nordisk
    Oramed Pharmaceuticals
    vTv Therapeutics
    Diabetology
    Generex Biotechnology
    Coromed
    Nektar Therapeutics

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Insulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Insulin, with price, sales, revenue and global market share of Oral Insulin from 2019 to 2024.
Chapter 3, the Oral Insulin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Insulin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Insulin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Insulin.
Chapter 14 and 15, to describe Oral Insulin sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oral Insulin
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Oral Insulin Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Type 1 Diabetes
        1.3.3 Type 2 Diabetes
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Oral Insulin Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Female
        1.4.3 Male
    1.5 Global Oral Insulin Market Size & Forecast
        1.5.1 Global Oral Insulin Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Oral Insulin Sales Quantity (2019-2030)
        1.5.3 Global Oral Insulin Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Novo Nordisk
        2.1.1 Novo Nordisk Details
        2.1.2 Novo Nordisk Major Business
        2.1.3 Novo Nordisk Oral Insulin Product and Services
        2.1.4 Novo Nordisk Oral Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novo Nordisk Recent Developments/Updates
    2.2 Oramed Pharmaceuticals
        2.2.1 Oramed Pharmaceuticals Details
        2.2.2 Oramed Pharmaceuticals Major Business
        2.2.3 Oramed Pharmaceuticals Oral Insulin Product and Services
        2.2.4 Oramed Pharmaceuticals Oral Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Oramed Pharmaceuticals Recent Developments/Updates
    2.3 vTv Therapeutics
        2.3.1 vTv Therapeutics Details
        2.3.2 vTv Therapeutics Major Business
        2.3.3 vTv Therapeutics Oral Insulin Product and Services
        2.3.4 vTv Therapeutics Oral Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 vTv Therapeutics Recent Developments/Updates
    2.4 Diabetology
        2.4.1 Diabetology Details
        2.4.2 Diabetology Major Business
        2.4.3 Diabetology Oral Insulin Product and Services
        2.4.4 Diabetology Oral Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Diabetology Recent Developments/Updates
    2.5 Generex Biotechnology
        2.5.1 Generex Biotechnology Details
        2.5.2 Generex Biotechnology Major Business
        2.5.3 Generex Biotechnology Oral Insulin Product and Services
        2.5.4 Generex Biotechnology Oral Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Generex Biotechnology Recent Developments/Updates
    2.6 Coromed
        2.6.1 Coromed Details
        2.6.2 Coromed Major Business
        2.6.3 Coromed Oral Insulin Product and Services
        2.6.4 Coromed Oral Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Coromed Recent Developments/Updates
    2.7 Nektar Therapeutics
        2.7.1 Nektar Therapeutics Details
        2.7.2 Nektar Therapeutics Major Business
        2.7.3 Nektar Therapeutics Oral Insulin Product and Services
        2.7.4 Nektar Therapeutics Oral Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Nektar Therapeutics Recent Developments/Updates

3 Competitive Environment: Oral Insulin by Manufacturer
    3.1 Global Oral Insulin Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Oral Insulin Revenue by Manufacturer (2019-2024)
    3.3 Global Oral Insulin Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Oral Insulin by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Oral Insulin Manufacturer Market Share in 2023
        3.4.2 Top 6 Oral Insulin Manufacturer Market Share in 2023
    3.5 Oral Insulin Market: Overall Company Footprint Analysis
        3.5.1 Oral Insulin Market: Region Footprint
        3.5.2 Oral Insulin Market: Company Product Type Footprint
        3.5.3 Oral Insulin Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Oral Insulin Market Size by Region
        4.1.1 Global Oral Insulin Sales Quantity by Region (2019-2030)
        4.1.2 Global Oral Insulin Consumption Value by Region (2019-2030)
        4.1.3 Global Oral Insulin Average Price by Region (2019-2030)
    4.2 North America Oral Insulin Consumption Value (2019-2030)
    4.3 Europe Oral Insulin Consumption Value (2019-2030)
    4.4 Asia-Pacific Oral Insulin Consumption Value (2019-2030)
    4.5 South America Oral Insulin Consumption Value (2019-2030)
    4.6 Middle East and Africa Oral Insulin Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Oral Insulin Sales Quantity by Type (2019-2030)
    5.2 Global Oral Insulin Consumption Value by Type (2019-2030)
    5.3 Global Oral Insulin Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Oral Insulin Sales Quantity by Application (2019-2030)
    6.2 Global Oral Insulin Consumption Value by Application (2019-2030)
    6.3 Global Oral Insulin Average Price by Application (2019-2030)

7 North America
    7.1 North America Oral Insulin Sales Quantity by Type (2019-2030)
    7.2 North America Oral Insulin Sales Quantity by Application (2019-2030)
    7.3 North America Oral Insulin Market Size by Country
        7.3.1 North America Oral Insulin Sales Quantity by Country (2019-2030)
        7.3.2 North America Oral Insulin Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Oral Insulin Sales Quantity by Type (2019-2030)
    8.2 Europe Oral Insulin Sales Quantity by Application (2019-2030)
    8.3 Europe Oral Insulin Market Size by Country
        8.3.1 Europe Oral Insulin Sales Quantity by Country (2019-2030)
        8.3.2 Europe Oral Insulin Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Oral Insulin Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Oral Insulin Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Oral Insulin Market Size by Region
        9.3.1 Asia-Pacific Oral Insulin Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Oral Insulin Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Oral Insulin Sales Quantity by Type (2019-2030)
    10.2 South America Oral Insulin Sales Quantity by Application (2019-2030)
    10.3 South America Oral Insulin Market Size by Country
        10.3.1 South America Oral Insulin Sales Quantity by Country (2019-2030)
        10.3.2 South America Oral Insulin Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Oral Insulin Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Oral Insulin Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Oral Insulin Market Size by Country
        11.3.1 Middle East & Africa Oral Insulin Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Oral Insulin Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Oral Insulin Market Drivers
    12.2 Oral Insulin Market Restraints
    12.3 Oral Insulin Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Oral Insulin and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Oral Insulin
    13.3 Oral Insulin Production Process
    13.4 Oral Insulin Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Oral Insulin Typical Distributors
    14.3 Oral Insulin Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Insulin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Oral Insulin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 4. Novo Nordisk Major Business
    Table 5. Novo Nordisk Oral Insulin Product and Services
    Table 6. Novo Nordisk Oral Insulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Novo Nordisk Recent Developments/Updates
    Table 8. Oramed Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 9. Oramed Pharmaceuticals Major Business
    Table 10. Oramed Pharmaceuticals Oral Insulin Product and Services
    Table 11. Oramed Pharmaceuticals Oral Insulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Oramed Pharmaceuticals Recent Developments/Updates
    Table 13. vTv Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 14. vTv Therapeutics Major Business
    Table 15. vTv Therapeutics Oral Insulin Product and Services
    Table 16. vTv Therapeutics Oral Insulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. vTv Therapeutics Recent Developments/Updates
    Table 18. Diabetology Basic Information, Manufacturing Base and Competitors
    Table 19. Diabetology Major Business
    Table 20. Diabetology Oral Insulin Product and Services
    Table 21. Diabetology Oral Insulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Diabetology Recent Developments/Updates
    Table 23. Generex Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 24. Generex Biotechnology Major Business
    Table 25. Generex Biotechnology Oral Insulin Product and Services
    Table 26. Generex Biotechnology Oral Insulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Generex Biotechnology Recent Developments/Updates
    Table 28. Coromed Basic Information, Manufacturing Base and Competitors
    Table 29. Coromed Major Business
    Table 30. Coromed Oral Insulin Product and Services
    Table 31. Coromed Oral Insulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Coromed Recent Developments/Updates
    Table 33. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 34. Nektar Therapeutics Major Business
    Table 35. Nektar Therapeutics Oral Insulin Product and Services
    Table 36. Nektar Therapeutics Oral Insulin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Nektar Therapeutics Recent Developments/Updates
    Table 38. Global Oral Insulin Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 39. Global Oral Insulin Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 40. Global Oral Insulin Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 41. Market Position of Manufacturers in Oral Insulin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 42. Head Office and Oral Insulin Production Site of Key Manufacturer
    Table 43. Oral Insulin Market: Company Product Type Footprint
    Table 44. Oral Insulin Market: Company Product Application Footprint
    Table 45. Oral Insulin New Market Entrants and Barriers to Market Entry
    Table 46. Oral Insulin Mergers, Acquisition, Agreements, and Collaborations
    Table 47. Global Oral Insulin Sales Quantity by Region (2019-2024) & (K Units)
    Table 48. Global Oral Insulin Sales Quantity by Region (2025-2030) & (K Units)
    Table 49. Global Oral Insulin Consumption Value by Region (2019-2024) & (USD Million)
    Table 50. Global Oral Insulin Consumption Value by Region (2025-2030) & (USD Million)
    Table 51. Global Oral Insulin Average Price by Region (2019-2024) & (US$/Unit)
    Table 52. Global Oral Insulin Average Price by Region (2025-2030) & (US$/Unit)
    Table 53. Global Oral Insulin Sales Quantity by Type (2019-2024) & (K Units)
    Table 54. Global Oral Insulin Sales Quantity by Type (2025-2030) & (K Units)
    Table 55. Global Oral Insulin Consumption Value by Type (2019-2024) & (USD Million)
    Table 56. Global Oral Insulin Consumption Value by Type (2025-2030) & (USD Million)
    Table 57. Global Oral Insulin Average Price by Type (2019-2024) & (US$/Unit)
    Table 58. Global Oral Insulin Average Price by Type (2025-2030) & (US$/Unit)
    Table 59. Global Oral Insulin Sales Quantity by Application (2019-2024) & (K Units)
    Table 60. Global Oral Insulin Sales Quantity by Application (2025-2030) & (K Units)
    Table 61. Global Oral Insulin Consumption Value by Application (2019-2024) & (USD Million)
    Table 62. Global Oral Insulin Consumption Value by Application (2025-2030) & (USD Million)
    Table 63. Global Oral Insulin Average Price by Application (2019-2024) & (US$/Unit)
    Table 64. Global Oral Insulin Average Price by Application (2025-2030) & (US$/Unit)
    Table 65. North America Oral Insulin Sales Quantity by Type (2019-2024) & (K Units)
    Table 66. North America Oral Insulin Sales Quantity by Type (2025-2030) & (K Units)
    Table 67. North America Oral Insulin Sales Quantity by Application (2019-2024) & (K Units)
    Table 68. North America Oral Insulin Sales Quantity by Application (2025-2030) & (K Units)
    Table 69. North America Oral Insulin Sales Quantity by Country (2019-2024) & (K Units)
    Table 70. North America Oral Insulin Sales Quantity by Country (2025-2030) & (K Units)
    Table 71. North America Oral Insulin Consumption Value by Country (2019-2024) & (USD Million)
    Table 72. North America Oral Insulin Consumption Value by Country (2025-2030) & (USD Million)
    Table 73. Europe Oral Insulin Sales Quantity by Type (2019-2024) & (K Units)
    Table 74. Europe Oral Insulin Sales Quantity by Type (2025-2030) & (K Units)
    Table 75. Europe Oral Insulin Sales Quantity by Application (2019-2024) & (K Units)
    Table 76. Europe Oral Insulin Sales Quantity by Application (2025-2030) & (K Units)
    Table 77. Europe Oral Insulin Sales Quantity by Country (2019-2024) & (K Units)
    Table 78. Europe Oral Insulin Sales Quantity by Country (2025-2030) & (K Units)
    Table 79. Europe Oral Insulin Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Oral Insulin Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Oral Insulin Sales Quantity by Type (2019-2024) & (K Units)
    Table 82. Asia-Pacific Oral Insulin Sales Quantity by Type (2025-2030) & (K Units)
    Table 83. Asia-Pacific Oral Insulin Sales Quantity by Application (2019-2024) & (K Units)
    Table 84. Asia-Pacific Oral Insulin Sales Quantity by Application (2025-2030) & (K Units)
    Table 85. Asia-Pacific Oral Insulin Sales Quantity by Region (2019-2024) & (K Units)
    Table 86. Asia-Pacific Oral Insulin Sales Quantity by Region (2025-2030) & (K Units)
    Table 87. Asia-Pacific Oral Insulin Consumption Value by Region (2019-2024) & (USD Million)
    Table 88. Asia-Pacific Oral Insulin Consumption Value by Region (2025-2030) & (USD Million)
    Table 89. South America Oral Insulin Sales Quantity by Type (2019-2024) & (K Units)
    Table 90. South America Oral Insulin Sales Quantity by Type (2025-2030) & (K Units)
    Table 91. South America Oral Insulin Sales Quantity by Application (2019-2024) & (K Units)
    Table 92. South America Oral Insulin Sales Quantity by Application (2025-2030) & (K Units)
    Table 93. South America Oral Insulin Sales Quantity by Country (2019-2024) & (K Units)
    Table 94. South America Oral Insulin Sales Quantity by Country (2025-2030) & (K Units)
    Table 95. South America Oral Insulin Consumption Value by Country (2019-2024) & (USD Million)
    Table 96. South America Oral Insulin Consumption Value by Country (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Oral Insulin Sales Quantity by Type (2019-2024) & (K Units)
    Table 98. Middle East & Africa Oral Insulin Sales Quantity by Type (2025-2030) & (K Units)
    Table 99. Middle East & Africa Oral Insulin Sales Quantity by Application (2019-2024) & (K Units)
    Table 100. Middle East & Africa Oral Insulin Sales Quantity by Application (2025-2030) & (K Units)
    Table 101. Middle East & Africa Oral Insulin Sales Quantity by Region (2019-2024) & (K Units)
    Table 102. Middle East & Africa Oral Insulin Sales Quantity by Region (2025-2030) & (K Units)
    Table 103. Middle East & Africa Oral Insulin Consumption Value by Region (2019-2024) & (USD Million)
    Table 104. Middle East & Africa Oral Insulin Consumption Value by Region (2025-2030) & (USD Million)
    Table 105. Oral Insulin Raw Material
    Table 106. Key Manufacturers of Oral Insulin Raw Materials
    Table 107. Oral Insulin Typical Distributors
    Table 108. Oral Insulin Typical Customers
List of Figures
    Figure 1. Oral Insulin Picture
    Figure 2. Global Oral Insulin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Oral Insulin Consumption Value Market Share by Type in 2023
    Figure 4. Type 1 Diabetes Examples
    Figure 5. Type 2 Diabetes Examples
    Figure 6. Global Oral Insulin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Oral Insulin Consumption Value Market Share by Application in 2023
    Figure 8. Female Examples
    Figure 9. Male Examples
    Figure 10. Global Oral Insulin Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Oral Insulin Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Oral Insulin Sales Quantity (2019-2030) & (K Units)
    Figure 13. Global Oral Insulin Average Price (2019-2030) & (US$/Unit)
    Figure 14. Global Oral Insulin Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Oral Insulin Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Oral Insulin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Oral Insulin Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Oral Insulin Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Oral Insulin Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Oral Insulin Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Oral Insulin Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Oral Insulin Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Oral Insulin Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Oral Insulin Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Oral Insulin Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Oral Insulin Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Oral Insulin Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Oral Insulin Average Price by Type (2019-2030) & (US$/Unit)
    Figure 29. Global Oral Insulin Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Oral Insulin Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Oral Insulin Average Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Oral Insulin Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Oral Insulin Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Oral Insulin Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Oral Insulin Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Oral Insulin Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Oral Insulin Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Oral Insulin Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Oral Insulin Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Oral Insulin Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Oral Insulin Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Oral Insulin Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Oral Insulin Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Oral Insulin Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Oral Insulin Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Oral Insulin Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Oral Insulin Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Oral Insulin Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Oral Insulin Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Oral Insulin Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Oral Insulin Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Oral Insulin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Oral Insulin Market Drivers
    Figure 73. Oral Insulin Market Restraints
    Figure 74. Oral Insulin Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Oral Insulin in 2023
    Figure 77. Manufacturing Process Analysis of Oral Insulin
    Figure 78. Oral Insulin Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Novo Nordisk
Oramed Pharmaceuticals
vTv Therapeutics
Diabetology
Generex Biotechnology
Coromed
Nektar Therapeutics